Better Choice Company Embraces a New Era with SRx Health Acquisition
The Better Choice Company is thrilled to announce significant strides towards finalizing its acquisition of SRx Health Solutions Inc. This union marks a vital step in enhancing the company’s footprint within the global health and wellness sector, particularly dedicated to fostering healthier lives for pets, families, and individuals alike.
Transforming the Future of Pet Health and Wellness
As we transition towards being a leading global entity in health and wellness, the merger with SRx Health is anticipated to propel both companies forward. By integrating our strengths, we project a robust combined revenue of approximately $270 million by 2025, along with an estimated EBITDA of $10 million. Such growth not only reflects our commitment to quality but also our dedication to operational efficiencies that will benefit our customers and stakeholders.
Strategic Goals and Vision
This acquisition is more than just numbers; it's about building a comprehensive ecosystem that places the health of pets and humans at the forefront. With Better Choice’s distinct approach to pet nutrition, combined with SRx Health’s innovative healthcare solutions, we are set to revolutionize the way pet health is perceived and managed, leading to better products and services available in the market.
Highlighting Recent Success and Market Integration
Better Choice has demonstrated impressive growth, particularly through our premium pet food brand, Halo. With gross sales soaring to approximately $49 million in 2023, we've successfully utilized an omni-channel distribution model that thrives both online and internationally. Notably, e-commerce sales constituted a substantial portion of our overall revenue.
Solid Financial Performance and Growth Trajectory
In the second quarter of 2024, we reported an adjusted EBITDA close to break-even, a clear indication of our progress towards stabilizing and evolving the business. Meanwhile, SRx Health has shown consistent performance, generating around CAD$180 million in revenue with positive adjusted EBITDA in 2023.
Expanding Horizons: The Path Ahead
As we look beyond this merger, our vision includes diversifying into new verticals such as veterinary medicine, slated to launch in 2025 with the "Better Pet Rx" initiative. This diversification not only complements our existing products but also leverages SRx Health’s established networks.
A Focus on Market Penetration
There remains untapped potential in the veterinary market and other geographic territories, including North America and Europe. Both companies are aligned in exploring these avenues with great enthusiasm, paving a sustainable path to long-term growth and success.
Shareholder Confidence and Future Outlook
For our shareholders, this merger signifies not just a growth opportunity but a transformation of our collective brand into a global health and wellness powerhouse. With a strong net tangible book value of $4.07 per share and net current asset value at $3.94, we believe the solid fundamental value will support our growth initiatives and reassure our investor community.
Moving Forward Together
We are grateful for the continued support of our shareholders as we approach the pivotal vote regarding the acquisition. Together, we are paving a promising future, and we are excited about the possibilities that this partnership will bring.
Frequently Asked Questions
What is the main purpose of the Better Choice and SRx Health merger?
The merger aims to create a leading global health and wellness company focused on providing innovative products and services for pets and their owners.
When is the expected closing date for the acquisition?
The transaction is expected to close in late Q4 2024 or early Q1 2025.
How will the merger impact shareholders?
The merger is projected to enhance shareholder value by generating significant revenue and operational efficiencies, positioning the company for robust growth.
What are the financial expectations post-merger?
Expectations for combined revenue and EBITDA by 2025 are approximately $270 million and $10 million respectively, promoting potential investment upside.
What initiatives will Better Choice pursue moving forward?
Better Choice plans to expand into veterinary medicine and explore new geographic markets, leveraging existing assets and networks to drive growth.
